An interventional study of Adapted Physical Activity (APA) in Anorexia Nervosa, Exercise Therapy and Videoconferencing, sponsored by University Hospital, Caen. Active, not recruiting at 1 site in France. Open to female participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-07-23.
Sponsored by University Hospital, Caen · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 79 studies in Anorexia Nervosa with a site in France — 16 open to participants now, 21 under way, 1 of them phase 3. Anorexia Nervosa · France.
Among the 79 studies in Anorexia Nervosa with a site in France, this one is the 35th largest by planned enrollment of the 48 interventional ones that give a count, is one of 5 that started in 2022, is one of 45 with no phase, reaches primary completion later than 5 of the 20 other live ones, and was the 62nd registered.
471 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.
Browse Anorexia Nervosa studies →16 of the 79 studies in Anorexia Nervosa with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier Esquirol · Sites in France
Ages 18–65
Centre Hospitalier St Anne · Sites in France
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 8–18
Hospices Civils de Lyon · Sites in France
Ages 15+ · Women only
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+ · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.
This study: 13 Years to 18 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
79 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 3
First in 2009; this study’s year is marked. 5 started in 2022.
This study's planned enrollment of 30 is below the median of 46 across 314 interventional studies indexed under Anorexia Nervosa.
Median enrollment 56 across the 48 interventional studies, 87 across the 31 observational. Of the 47 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 79 has an industry lead sponsor. The 10 most frequent:
University Hospital, Caen is the lead sponsor of 515 studies on the registry; 84 are open to participants now.
University Hospital, Caen has 1 study filed under Anorexia Nervosa — fewer than ten, so there is no comparison to draw.
9 of the studies in Anorexia Nervosa with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06091306Assistance Publique - Hôpitaux de ParisQualitative Evaluation of Change Processes in Multifamily Therapy for Adolescents With Anorexia Nervosa | 2026-12 |
| NCT05770089University Hospital, CaenVideoconferencing Adapted Physical Activity in Anorexia Nervosa: a Pilot Study | 2026-12-01 |
| NCT04107870CHU de ReimsEfficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa | 2027-03-20 |
| NCT07411807Centre Hospitalier St AnneStudy of the Effectiveness of a Systematic Minimal Early Intervention on Care Engagement in Adults With Eating Disorders Requesting Specialized Treatment. | 2027-04 |
| NCT05477537Fondation Santé des Étudiants de FranceAdapted Physical Activity in the Treatment of Anorexia: | 2027-04 |
Add all 9 to your calendar (.ics) → With an account.
Among the 79 studies in Anorexia Nervosa with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary objectives of the APAREXIM'Pilot study are to evaluate the short- and medium-term effects of a live supervised Adapted Physical Activity (APA) program via videoconferencing on:
The secondary objectives are to evaluate the impact of this program on :
The patients will first undergo an inclusion visit (T0) at the University Hospital of Caen, then a first evaluation session (T1) at the COMETE laboratory in Caen (physical tests, questionnaires, sleep diary, actimetry). They will then be randomly divided into 2 groups: 15 patients who will follow an APA program supervised by videoconference for 8 weeks (AM-APA) at their home, in addition to the usual outpatient treatment, and 15 patients who will benefit only from the classic outpatient treatment (AM-T). All patients will undergo two additional evaluation sessions at one week post-program (T2) and at 3 months post-program (T3).
Background: Anorexia nervosa (AN) is an eating disorder (ED), mainly in women, characterized by strict and voluntary food deprivation over a long period of time, which can last from several months to several years, leading to significant weight loss. This disease affects 2.2 to 4% of the general population in Europe and is one of the most fatal psychiatric diseases in people under 25 years old. Physiological and psychological disorders are very often associated with AN, as well as an alteration of the sleep-wake cycle. In order to reduce the risk of chronicity of the disease and to prevent its various complications in young women, early and multidisciplinary therapeutic management is recommended by public health authorities. However, this management remains long and complex due to the diversity and severity of the symptoms, a lack of adherence of patients to treatment protocols, but also a lack of therapeutic continuity after hospitalization. Recently, new non-medicinal therapies based on Adapted Physical Activity (APA) have been developed to prevent and reduce the main symptoms of AN and associated disorders in an effective and lasting way. However, to our knowledge, interventional research in this field remains scarce and presents limited results. Furthermore, the scientific literature does not report any evaluation of the feasibility, acceptability, and effectiveness of a home video-conference-supervised APA intervention with AN patients.
Objectives: The primary objectives of the APAREXIM'Pilot study are to evaluate the short- and medium-term effects of a live supervised APA program via videoconferencing on feasibility and acceptability of APA via videoconferencing by the patients and the primary symptoms of AN. The secondary objectives are to evaluate the impact of this program on mental health, physical condition and the sleep-wake cycle (sleep disturbance and physical hyperactivity), as well as its.
Method: This randomized controlled intervention study will be conducted with 30 adolescent and young adult girls with AN. The patients will first undergo an inclusion visit (T0) at the University Hospital of Caen, then a first evaluation session (T1) at the COMETE laboratory in Caen (physical tests, questionnaires, sleep diary, actimetry). They will then be randomly divided into 2 groups: 15 patients who will follow an APA program supervised by videoconference for 8 weeks (AM-APA) at their home, in addition to the usual outpatient treatment, and 15 patients who will benefit only from the classic outpatient treatment (AM-T). All patients will undergo two additional evaluation sessions at one week post-program (T2) and at 3 months post-program (T3).
Perspectives: The results obtained will allow to evaluate the acceptability and the feasibility of a distance APA program, and to bring additional evidence of the effectiveness of an APA intervention in patients with AM, as well as elements of understanding of the regulation of this pathology by APA. In addition, the APAREXIM'Pilot study will allow to test and validate an APA program for patients with AM, which could eventually be integrated in the management of patients on the national territory.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The group following the Adapted Physical Activity program via videoconferencing in addition to the outpatient care.
Other: Adapted Physical Activity (APA)
The group without additional intervention other than the outpatient care.
A 8-weeks program of APA (2x1hour per week) via videoconferencing composed of resistance training and yoga.
Also known as: Interventional exercise therapy
Treatment Acceptability and Preferences questionnaire (TAP-Q)
Questionnaire (scale) assessing the acceptability of the APA program via videoconferencing (high score mean better outcome).
Time frame: T2 (just after the APA program)
Eating Attitude Test - 26 (EAT-26)
Questionnaire (scale) assessing the severity of main anorexic symptoms (high score mean worse outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Hospital Anxiety and Depression (HAD) scale
Questionnaire (scale) assessing anxious and depressive symptoms (high score mean worse outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Rosenberg Self-esteem Scale (RSS)
Questionnaire (scale) assessing self-esteem (high score mean better outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Contour Drawing Rating Scale (CDRS)
Questionnaire (scale) assessing self-esteem (high score mean worse outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Body Esteem Scale (BES)
Questionnaire (scale) assessing body esteem (high score mean better outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Exercise Dependence Scale Revised
Questionnaire (scale) assessing exercise dependence (high score mean worse outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Questionnaire (scale) assessing interoceptive awareness (high score mean better outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Pittsburgh Sleep Quality Index (PSQI)
Questionnaire (scale) assessing sleep quality (high score mean worse outcome).
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Actimetry
One week of actimetry with an accelerometer watch measuring 7x24h activity counts allowing to extract day and night activity level.
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Body Mass Index (BMI)
Measure of body weight and height to compute the BMI
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Body composition - Body cellular mass
Bio-impedance measuring of body cellular mass
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Body composition - Fat mass
Bio-impedance measuring of body fat mass
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Body composition - Fat free mass
Bio-impedance measuring of body fat-free mass
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Body composition - Total body water
Bio-impedance measuring of total body water
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Body composition - Extracellular water
Bio-impedance measuring of body extracellular water
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Isokinetic assessment of upper and lower limbs
Isokinetic peak torque (concentric contraction at 60°/sec and 240°/sec) of forearm and leg flexion/extension.
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Back extension strength
Assessment of the back extension strength with a dynamometer
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Shirado test
Assessment of the isometric back flexion endurance with the Shirado test
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Sorensen test
Assessment of the isometric back extension endurance with the Sorensen test
Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2022 (actual). Primary completion is estimated for Dec 2026, 48 months after the start.
Of 149 non-industry interventional studies with no phase under Anorexia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 48 months is above that.
Counting every sponsor, half of 149 studies reached it within 43 months; a quarter within 24 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.